| Date | Form | Description | Docs | XBRL | Pages |
| 08/26/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/19/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 07/05/16 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 07/05/16 | DEF 14A | Definitive proxy statements |
|
46 | |
| 07/05/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/29/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/20/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/13/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/10/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/06/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
Read More...Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
Read More...Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
Read More...